PURPOSE National estimates of cancer clinical trial participation are nearly two decades old
and have focused solely on enrollment to treatment trials, which does not reflect the …

Multi-cancer early detection (MCED) tests are blood-based tests designed to screen for
signals of multiple cancers. There is growing interest and investment in examining the …

Importance Racial and ethnic disparities in clinical trial enrollment are unjust and hinder
development of new cancer treatments. Objective To examine the association of race and …

Tumours of the appendix—a vestigial digestive organ attached to the colon—are rare.
Although we estimate that around 3,000 new appendiceal cancer cases are diagnosed …

The metrics of success for oncology drug development and approval shifted with the shorter
time to approval associated with the US Food and Drug Administration (FDA) 2018 Real …

Background Expanding access to clinical trials in community settings is a potential approach
to addressing disparities in accrual of historically underrepresented populations. However …

Purpose Lenvatinib was approved for the treatment of patients with radioiodine-refractory
differentiated thyroid cancer (RAI-R DTC) in the United States (US) in 2015. The main …

Disparities in Clinical Trial Enrollment– Focus on CAR-T and Bispecific Antibody Therapies |
Current Hematologic Malignancy Reports Skip to main content Springer Nature Link Account …

Cultural beliefs, personal experiences, and historic abuses within the healthcare system—
rooted in structural racism—all contribute to community distrust in science and medicine …

The first experimental use of chemotherapy was conducted in 1942 using nitrogen mustard
to treat non-Hodgkin lymphoma, 1, 2 marking the beginning of modern chemotherapy …